Photo of Hagen Kennecke taken from ohsu.edu
Sep 18, 2024, 12:58
Hagen Kennecke: Possible breakthrough in cancer cachexia with Ponsegromab
Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared on X:
“Possible breakthrough in cancer cachexia with Ponsegromab, anti-GDF 15. Significant weight gain, especially in patients with colorectal cancer.”
Ponsegromab for the Treatment of Cancer Cachexia | NEJM
Authors: John D. Groarke, Jeffrey Crawford, Susie M. Collins, Shannon Lubaczewski, Eric J. Roeland, Tateaki Naito, Andrew E. Hendifar, Marie Fallon, Koichi Takayama, Timothy Asmis, Richard F. Dunne, M.D., Isik Karahanoglu, Carrie A. Northcott, Magdalena A. Harrington, Michelle Rossulek, Ruolun Qiu, Aditi R. Saxena
Source: Hagen Kennecke/X
Aditi R. Saxena
Andrew E. Hendifar
cancer
cancer cachexia
Carrie A. Northcott
Eric J. Roeland
Hagen Kennecke
Isik Karahanoglu
Jeffrey Crawford
John D. Groarke
Koichi Takayama
M.D.
Magdalena A. Harrington
Marie Fallon
Michelle Rossulek
ocnology
OncoDaily
Ponsegromab
Richard F. Dunne
Ruolun Qiu
Shannon Lubaczewski
Susie M. Collins
Tateaki Naito
Timothy Asmis
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19